Document Detail


Intra-arterial therapies for hepatocellular carcinoma: where do we stand?
MedLine Citation:
PMID:  20405328     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE AND DESIGN: Intra-arterial therapies for unresectable hepatocellular carcinoma (HCC) consist of a catheter-based group of treatments where therapeutic and/or embolic agents are intra-arterially directed to target tumors. Here we review these therapies, which may be classified into embolotherapy/chemotherapy-based and radiotherapy-based treatments. Embolotherapy/chemotherapy-based treatments include transcatheter arterial embolization, transarterial chemoembolization, transcatheter arterial chemoeinfusion, and chemoembolization with drug-eluting beads. Radiotherapy-based treatments include radioembolization with yttrium-90 and injection of iodine-131-labeled lipiodol.
RESULTS AND CONCLUSION: Interpretation of the results of clinical trials as well as implementation of meta-analyses involving the efficacy of intra-arterial therapies for unresectable HCC has been challenging and difficult to perform. The levels of evidence for treatment recommendations in oncology provide a common framework to understand the current status of intra-arterial therapies for HCC. Here we use an evidence-based approach to critically review and comprehend the current role and future potential of intra-arterial therapies in unresectable HCC.
Authors:
Eleni Liapi; Jean-Francois H Geschwind
Related Documents :
3497528 - Intraarterial fibrinolytic therapy for popliteal and tibial artery obstruction: compari...
11354758 - Intra-arterial thrombolysis for acute ischemic stroke.
20659118 - Selective regional perfusion of the bilateral external carotid arteries with pegylated ...
9327688 - Relation between injections before 90-minute angiography and coronary patency: results ...
17531588 - Association of multiple inflammatory markers with carotid intimal medial thickness and ...
16385928 - Retained percutaneous transluminal coronary angioplasty guidewire in coronary circulation.
Publication Detail:
Type:  Journal Article; Review     Date:  2010-04-20
Journal Detail:
Title:  Annals of surgical oncology     Volume:  17     ISSN:  1534-4681     ISO Abbreviation:  Ann. Surg. Oncol.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-20     Completed Date:  2010-07-29     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  9420840     Medline TA:  Ann Surg Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1234-46     Citation Subset:  IM    
Affiliation:
The Russell H Morgan Department of Radiology and Radiological Science, Division of Vascular and Interventional Radiology, The Johns Hopkins Hospital, Baltimore, MD, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / therapeutic use
Carcinoma, Hepatocellular / therapy*
Catheter Ablation
Embolization, Therapeutic*
Humans
Infusions, Intra-Arterial*
Liver Neoplasms / therapy*
Radiotherapy Dosage
Chemical
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.
Next Document:  Systemic treatment of hepatocellular carcinoma: dawn of a new era?